XML 37 R87.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation - Summary of the Activity for Stock Option Awards (Details) (Stock options, USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Jan. 27, 2013
Jan. 29, 2012
Jan. 30, 2011
Stock options
     
Number of Shares      
Beginning balance (in shares) 3,690 6,622 9,151
Options granted (in shares) 258 343 403
Options exercised (in shares) (1,254) (2,781) (2,329)
Options cancelled/forfeited (in shares) (115) (494) (603)
Ending balance (in shares) 2,579 3,690 6,622
Exercisable at end of the period (in shares) 1,937    
Options vested and expected to vest after period (in shares) 2,495    
Weighted Average Exercise Price (per share)      
Beginning balance (in dollars per share) $ 16.94 $ 16.84 $ 16.44
Options granted (in dollars per share) $ 28.21 $ 24.05 $ 17.61
Options exercised (in dollars per share) $ 15.70 $ 16.64 $ 14.22
Options forfeited (in dollars per share) $ 25.30 $ 22.30 $ 21.35
Ending balance (in dollars per share) $ 18.29 $ 16.94 $ 16.84
Exercisable at end of the period (in dollars per share) $ 16.51    
Options vested and expected to vest after January 27, 2013 (in dollars per share) $ 18.10    
Aggregate Intrinsic Value      
Beginning balance $ 44,435 [1] $ 35,492 [1] $ 8,998 [1]
Options exercised 14,508 [1] 22,537 [1] 11,495 [1]
Ending balance 29,789 [1] 44,435 [1] 35,492 [1]
Exercisable at end of the period 25,822 [1]    
Vested and expected to vest after period end 29,293 [1]    
Aggregate Unrecognized Compensation      
Beginning balance 4,699 7,067 9,436
Ending balance $ 3,817 $ 4,699 $ 7,067
Number of Shares Exercisable      
Beginning balance 2,767 5,160 6,302
Ending balance 1,937 2,767 5,160
Weighted Average Contractual Term      
Exercisable at end of the period 2 years 0 months 25 days    
Vested and expected to vest after period end 2 years 7 months 6 days    
[1] Represents the difference between the exercise price and the value of the Company’s stock at the time of exercise, for exercised grants. For outstanding awards, represents the difference between the exercise price and the value of the Company’s stock at fiscal year end.